Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More


Singapore Clinical Trial: A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects with Moderate-to-Severe Active Thyroid Eye Disease

Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety... Read More


Singapore Clinical Trial: Immunogenicity of Recombinant Zoster Vaccine in Long-term Solid Organ Transplant Recipients

Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'Immunogenicity of Recombinant Zoster Vaccine in Long-term Solid Organ Transplant Recipients'. The ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More


Singapore Clinical Trial: Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome

Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome'.... Read More


Clinical Trial: The Effect of a Mobile Application-Supported Mindful Caring Education Program

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07702006) titled 'The Effect of a Mobile Application-Supported Mindful Caring Education Program' on July 06. ... Read More


Singapore Clinical Trial: A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy (ACT-EARLY OLE)

Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed... Read More


Singapore Clinical Trial: Healthy longevity with rapamycin (LONGER)

Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'Healthy longevity with rapamycin (LONGER)'. The following are the other relevant details related t... Read More


Singapore Clinical Trial: FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma

Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma... Read More


Singapore Clinical Trial: Efficacy and safety of LUCONAC ® External Solution for the treatment of Onychomycosis in anopen label head-to-head comparison with Amorolfine Nail Lacquer.

Singapore, July 15 -- The Health Sciences Authority received information related to the study titled 'Efficacy and safety of LUCONAC ® External Solution for the treatment of Onychomycosis in anopen la... Read More